Patrick Karl
Interventional Pain Medicine · Jesup, GANPI 1073795142
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 166 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $784 and has fallen 66.0% since, to $267 in 2022. That places this record below the midpoint for interventional pain medicine clinicians in GA, where the typical reported total is $4,377.
Across 166 payments — averaging $14.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biodelivery Sciences International, Inc.$498
- Boston Scientific$362
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$329
- Nevro Corp.$310
- Collegium Pharmaceutical, Inc.$219
- Forte Bio-pharma LLC$100
- plus $595 from 16 others
What the payments were for
- Food & beverage$2,39299%
- Education$211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biodelivery Sciences International, Inc. | 47 | $498 |
| Boston Scientific | 25 | $362 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 26 | $329 |
| Nevro Corp. | 11 | $310 |
| Collegium Pharmaceutical, Inc. | 16 | $219 |
| Forte Bio-pharma LLC | 2 | $100 |
| Supernus Pharmaceuticals, Inc. | 6 | $88 |
| Redhill Biopharma Inc. | 5 | $82 |
| Biohaven Pharmaceuticals, Inc. | 4 | $75 |
| Pfizer | 5 | $72 |
| Virtus Pharmaceuticals LLC | 3 | $51 |
| Amgen | 3 | $40 |
| AbbVie(2 entities) | 3 | $37 |
| Novartis | 2 | $31 |
| Hikma Pharmaceuticals USA | 1 | $21 |
| Shionogi Inc | 1 | $19 |
| Almatica Pharma LLC | 1 | $15 |
| GRT US Holding, Inc. | 1 | $15 |
| Scilex Pharmaceuticals Inc. | 1 | $14 |
| Medtronic | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Daiichi Sankyo Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,413 in reported general payments places this provider in the 40th percentile of 129 interventional pain medicine providers in Georgia.
Other interventional pain medicine in Jesup
- Emmanuel GageBrunswick$602K
- Jordan TateJasper$540K
- Christopher BovinetBrunswick$338K
- David RosenfeldCovington$249K
- Nathan NeufeldNewnan$171K
- Ryan BudwanyLawrenceville$123K
- Alexandra MoreiraAtlanta$79K
- Sushanth BodaNewnan$55K
- Christopher AndrianoStockbridge$41K
- Guensley DelvaWaycross$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.